key: cord-1044575-z0srbt43
authors: Jayaraj, Rama
title: Clinical and conceptual comments on “Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis”
date: 2020-05-11
journal: J Infect
DOI: 10.1016/j.jinf.2020.05.011
sha: 56a11bae6ac6ab6e9c6aa5de3d7ecb37fbd3cdb9
doc_id: 1044575
cord_uid: z0srbt43

nan

To the Editor, Currently research on COVID-19 has been prioritised globally with a high frequency of the articles being published in the literature. The incidence of false-negative tests for "happy hypoxia" in asymptomatic patients, evolving epidemiological characteristics, and the universal risk of infection in every single age group with unpredictable capricious outcomes, explains the need to explore the risk factors associated with the novel coronavirus. The systematic review and meta-analysis on COVID-19 by Zheng et al. contribute to this global research output, and attempts to inform clinical decision making during this crisis 1 . Nevertheless, there are a few recommendations that we would like to put forth in order to make the study robust enough to inform future decision making. Few additional risk factors missing in the study: The epidemiology and clinical pattern of paediatric COVID 19 has a unique spectrum with infants and young children ≤ 5 years more likely to succumb to severe clinical symptoms of COVID19 than older children (i.e., ≥ 6 years). The immaturity of the immune system is cited as a plausible explanation 1 . Children can swiftly progress to acute respiratory distress syndrome (ARDS). They may also have shock, encephalopathy, myocardial injury or heart failure, coagulation dysfunction, and acute kidney injury.

The forgotten "Cancer": The unprecedented outbreak of COVID-19 has caused a substantial risk for cancer patients who are immunocompromised due to the disease and its treatment 2 .

We noted that the authors used the fixed-effect model to perform the meta-analysis. The fixed-effects model is practically applied when the studies across which the data is being pooled have, similar study parameters, and are devoid of any major heterogeneity. Hence, this model is often used to assess cohorts within a singular larger study. Nevertheless, the meta-analysis by Zhang et al., where multiple different studies are used, are inherently predisposed to heterogeneity due to the differential protocols and parameters of individual study. We propose the "random effects model" for this study. 3, 4 .

Analysis of heterogeneity: Furthermore, although the analysis of heterogeneity was conducted using the commonly used I 2 statistic, it may not have sufficient power by itself to determine between-study heterogeneity. The I 2 statistic has shown to be limited in its application; nonetheless we recommend the authors also asses heterogeneity via the Cochran"s Q statistic and the Tau 2 statistic, which would add redundancy and robustness in the analysis of heterogeneity in this study 5 .

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China

Fixed-and random-effects models in meta-analysis

Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis

Meta-analysis of penile cancer: conceptual interpretations. The Lancet Oncology

Conceptual, statistical and clinical interpretation of results from a systematic review and meta-analysis of prevalence of cervical HPV infection in women with SLE

Bias in meta-analysis detected by a simple, graphical test

Authors' contributions RJ predominantly conceived this review and led the development of the letter to the editor. RJ, SSS and CK wrote the first draft of the letter, and GR, SSS, RRM, and PS critically revised and edited successive drafts of the manuscript. All authors read and approved the final version of the manuscript.